ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by CenterBook Partners LP

CenterBook Partners LP lowered its position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 17.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 151,505 shares of the company's stock after selling 32,338 shares during the quarter. CenterBook Partners LP owned approximately 0.55% of ZimVie worth $2,113,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of ZIMV. Geode Capital Management LLC raised its position in ZimVie by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company's stock valued at $10,263,000 after purchasing an additional 15,053 shares during the last quarter. American Century Companies Inc. increased its stake in ZimVie by 23.9% in the fourth quarter. American Century Companies Inc. now owns 628,050 shares of the company's stock valued at $8,761,000 after purchasing an additional 121,053 shares during the period. Russell Investments Group Ltd. raised its holdings in shares of ZimVie by 1.7% in the fourth quarter. Russell Investments Group Ltd. now owns 276,443 shares of the company's stock valued at $3,856,000 after buying an additional 4,739 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of ZimVie by 33.6% in the fourth quarter. First Eagle Investment Management LLC now owns 267,971 shares of the company's stock valued at $3,738,000 after buying an additional 67,400 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of ZimVie by 18.7% during the fourth quarter. JPMorgan Chase & Co. now owns 217,773 shares of the company's stock worth $3,038,000 after buying an additional 34,354 shares during the period. 95.63% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ZIMV. B. Riley started coverage on ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 price target on the stock. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Stock Performance

ZimVie stock traded down $0.19 during trading hours on Tuesday, reaching $9.25. 41,841 shares of the stock were exchanged, compared to its average volume of 225,290. ZimVie Inc. has a 52-week low of $8.56 and a 52-week high of $22.40. The stock has a market cap of $257.58 million, a P/E ratio of -0.71 and a beta of 2.14. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The firm's 50 day moving average is $11.88 and its 200 day moving average is $13.44.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The firm had revenue of $111.52 million during the quarter, compared to analysts' expectations of $113.67 million. Analysts predict that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.